Related Experiment Video
Updated: Jul 1, 2026

Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Prognostic Factors for Vulvar Cancer Undergoing Primary Surgery: Case Series from a Single Tertiary Cancer Center
T S Shylasree1,2, Ushashree Das1,3, Neha Kumar1,4
1Department of Gynecological Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Room No. 1211, Homi Bhabha Block, Dr Ernest Borges Marg, Parel, Mumbai, 400012 Maharashtra India.
Primary surgery for vulvar squamous cell carcinoma (SCC) shows depth of invasion, tumor-free margin, and perineural invasion are key factors for disease-free survival. Recurrence risk is linked to these factors and groin metastases.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Cancer Research
Background:
- Vulvar squamous cell carcinoma (SCC) is a rare malignancy.
- Primary surgical management is the cornerstone of treatment.
- Identifying prognostic factors is crucial for patient outcomes.
Purpose of the Study:
- To evaluate clinical outcomes in women undergoing primary surgery for vulvar SCC.
- To identify clinicopathological risk factors associated with recurrence and survival.
Main Methods:
- Retrospective cohort analysis of 81 patients (2011-2018).
- Kaplan-Meier method for disease-free survival (DFS) and overall survival (OS) estimation.
- Univariate and multivariate Cox proportional hazards models were used.
Main Results:
- Recurrence occurred in 33.3% of patients; median DFS was 36 months.
- Median OS was 40.8 months.
- Univariate analysis identified depth of invasion (DOI), close margin, lympho-vascular space invasion (LVSI), perineural invasion (PNI), and groin metastases as risk factors for recurrence.
- Multivariate analysis revealed DOI, tumor-free margin (TFM), and PNI significantly impacted DFS, while prior recurrence affected OS.
Conclusions:
- Local tumor factors like TFM, DOI, LVSI, and lymph node status are critical for oncological outcomes in vulvar SCC.
- These findings aid in determining prognosis after primary surgical treatment.
- Larger studies are needed to further validate these prognostic indicators.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024